Who We Are
We are a growing international specialist healthcare company. Our mission is to bring to market medical products that meet the needs of specialist healthcare physicians and their patients.
We are focused on three business areas: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
Our Interventional Medicines include Interventional Oncology products used to treat patients with liver tumours and Interventional Vascular products used to treat patients with severe blood clots and patients with varicose veins in the great saphenous vein system of the leg.
Our Specialty Pharmaceutical products include antidotes to treat snake envenomation and toxicity associated with medicines used for heart conditions and cancer.
We develop our own products and in-license or acquire them from others. We sell direct to our customers in the US and elsewhere principally through distribution partners.
In everything we do, we are guided by our core values and our Code of Conduct. We believe that by doing the right thing we will deliver enduring value to all our stakeholders.
BTG at a glance
Our latest Corporate Profile provides a snapshot of us today.
Download document (PDF - 110KB)